Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases
Seminars in Immunopathology · 2025-12 · 47 (1)
DOI: 10.1007/s00281-025-01036-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 27.01.2025. Verfasst von Konstantina Atanasova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany. Konstantina.Atanas…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Mental Disorders. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Deutsche Forschungsgemeinschaft, Medizinische Fakultät Mannheim der Universität Heidelberg.
Abstract (Originalsprache)
The brain-gut axis constitutes the basis for the bidirectional communication between the central nervous system and the gastrointestinal tract driven by neural, hormonal, metabolic, immunological, and microbial signals. Alterations in the gut microbiome composition as observed in inflammatory bowel diseases can modulate brain function and emerging empirical evidence has indicated that interactions among the brain-gut microbiome-axis seem to play a significant role in the pathogenesis of both inflammatory bowel diseases and psychiatric disorders and their comorbidity. Yet, the immunological and molecular mechanisms underlying the co-occurrence of inflammatory bowel diseases and psychological symptoms are still poorly understood. The aim of this narrative review is to highlight contemporary empirical findings supporting a pivotal role of the gut microbiome in the pathophysiology of highly prevalent neuropsychiatric symptoms in inflammatory bowel diseases such as fatigue, depression, and anxiety. Finally, we focus on microbiome modulation as potential treatment option for comorbid neuropsychiatric symptoms in immune-mediated diseases and especially in inflammatory bowel diseases. High-quality clinical trials are required to clarify how microbiome modulation through dietary interventions or probiotic, prebiotic or synbiotic treatment can be used clinically to improve mental health and thus quality of life of patients with inflammatory bowel diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany. Konstantina.Atanasova@zi-mannheim.de.
- Department of Psychosomatic Medicine, Medical Faculty Mannheim, Central Institute for Mental Health Mannheim, Heidelberg University, Mannheim, Germany. Konstantina.Atanasova@zi-mannheim.de.
- Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Förderung
- German Research Foundation
- Deutsche Forschungsgemeinschaft
- Medizinische Fakultät Mannheim der Universität Heidelberg
Zitieren
APA
Atanasova, K., Knödler, L. L., Reindl, W., Ebert, M. P., & Thomann, A. K. (2025). Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases. Seminars in Immunopathology, 47(1). https://doi.org/10.1007/s00281-025-01036-x
Vancouver
Atanasova K, Knödler LL, Reindl W, Ebert MP, Thomann AK. Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases. Seminars in Immunopathology. 2025;47(1). doi:10.1007/s00281-025-01036-x
BibTeX
@article{Atanasova2025,
author = {Atanasova, Konstantina and Knödler, Laura-Louise and Reindl, Wolfgang and Ebert, Matthias Philip and Thomann, Anne Kerstin},
title = {Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases},
journal = {Seminars in Immunopathology},
year = {2025},
volume = {47},
number = {1},
doi = {10.1007/s00281-025-01036-x}
}
EUVIMED